A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin
Status:
Withdrawn
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This multi-center, randomized, double-blind, placebo-controlled, parallel-group study will
evaluate the efficacy, safety and tolerability of RO6811135 in Type 2 diabetic patients
treated with a stable dose of metformin.